InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Holiday mail will cost more this year as stamp prices rise again. Here’s how much your cards will cost you now.

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...

It turns out many districts aren’t implementing high-impact tutoring programs effectively. In Philadelphia, school leaders ...

A study of five waterways, including the River Lagan and Lough Neagh, finds cocaine and its by-product in 91% of almost 140 ...

In a post-Metsera world, Structure Therapeutics could be the next big takeover candidate, analysts said Tuesday.

BlackRock, Inc. ( BLK) Goldman Sachs 2025 U.S. Financial Services Conference December 9, 2025 2:20 PM EST ...